首页> 中文期刊> 《实用临床医药杂志》 >非小细胞肺癌中RAD51、ERCC2和BAG-1基因多态性与临床病理特征的关系

非小细胞肺癌中RAD51、ERCC2和BAG-1基因多态性与临床病理特征的关系

         

摘要

目的:探讨DNA损伤修复基因RAD51和切除修复交叉互补基因(ERCC2)/着色性干皮病基因(XPD )ERCC2/XPD以及Bcl-2结合抗凋亡基因1(BAG-1)基因多态性与非小细胞肺癌临床病理特征的关系。方法采用病例对照研究设计,选取100例非小细胞肺癌病例和80例正常对照。选取ERCC2/XPD Lys751Gln和RAD51 codon 135以及BAG-1codon 324基因多态性为研究位点,以聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行多态性检测,应用Logistic回归计算OR值及95%CI,比较不同基因型与非小细胞肺癌发病风险的关系,并分析与非小细胞肺癌临床病理学特征的相关性。结果与野生基因型C/C型相比,携带ERCC2/XPD C/A基因型和A/A基因型者患非小细胞肺癌的OR分别是1.53(95%CI:1.15~3.32)和0.58(95%CI:0.15~2.39);与野生基因型G/G型相比,RAD51 G/C基因型者患NSCLC的OR是1.03(95%CI:1.06~2.29)。与野生基因型C/C型相比,携带BAG-1C/T基因型者患NSCLC的OR是1.28(95% CI:1.08~2.74);ER-CC2/XPD C/A和A/A基因型多态性与淋巴结转移状态有相关性(P=0.038,OR=2.26,95%CI:1.69~3.59);与远处转移几率的相关性更好P=0.005,OR=2.47,95%CI:1.38~4.24)。BAG-1 codon 324 C/T型,RAD51 codon 135 G/C型基因多态性与淋巴结转移状态有相关性(P=0.042,OR=2.57,95%CI:1.62~4.44和P=0.049和OR=2.86,95%CI:1.39~3.62)。结论 DNA损伤修复基因ERCC2/XPD和RAD51以及BAG-1基因多态性增加了非小细胞肺癌发生的风险,ERCC2/XPD和RAD51以及BAG-1基因多态性改变与非小细胞肺癌患者的淋巴结及远处转移密切相关。%Obj ective To explore the relationship between xeroderma pigmentosum group D (ERCC2/XPD),Bcl-2 associated athanogene 1 (BAG-1 )and DNA repair gene RAD5 1 polymor-phism and clinicopathological characteristics of non-small cell lung cancer (NSCLC).Methods A case-control study with 100 NSCLC cases and 80 controls matched by age and sex was conducted, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP )was ana-lyzed.Logistic regression model was made to calculate the odd ratios (ORs)and detect 95%confi-dence intervals (CIs)of ERCC2/XPD Lys751Gln,BAG-1codon 324 and RAD51 codon 135 with susceptibility of NSCLC.Unconditional Logistic regression model adj usted by the confounding fac-tors was used to analyze the correlation between the polymorphism genotypes and the risk of NSCLC and clinicopathological characteristics.Results The odds ratios for individuals carrying ERCC2/XPD C/A and A/A were 1.53(95%CI:1.15~3.32)and 0.58 (95% CI:0.15~2.39).The odds ratios for individuals carrying BAG-1 C/T was 1.28(95%CI:1.08~2.74).The odds ratios for individuals carrying RAD51 G/C was 1.03(95%CI:1.06~2.29).ERCC2/XPD C/A and A/A polymorphisms genotype frequencies were significantly related to the invasive characteristics of NSCLC [lymph node metastasis:(P= 0.038,OR= 2.26,95% CI:1.69~3.59),distant metastasis:(P= 0.005,OR= 2.47,95%CI:1.38~4.24)].As the same BAG-1 codon 324 C/T and RAD51 codon 135 G/C polymorphisms genotype frequencies (P= 0.042,OR= 2.57, 95%CI:1.62~4.44 and P= 0.049,OR= 2.86,95%CI:1.39~3.62).Conclusion Genet-icpolymorphism of ERCC2/XPD,BAG-1 and RAD5 1 are associated with the susceptibility to NSCLC.ERCC2/XPD,BAG-1 and RAD51gene polymorphism in Chinese Han population in-creases susceptibility to NSCLC risk and the changes of ERCC2/XPD C/A and A/A,BAG-1codon 324 C/T and RAD51 codon 135 G/C polymorphism are closely related to lymph node and distant metastasis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号